- The Chinese GPU maker says its new BR20X flagship chip has entered post-tape-out validation
- But a discounted share placement has raised fresh questions about the company’s funding needs and path to profitability
Chinese GPU maker Biren Technology (壁仞科技) said its flagship BR20X chip has powered on successfully, but investor concerns sent its shares plunging nearly 12% as a fresh fundraising plan overshadowed the technical milestone.
Known as one of China’s “GPU quartet,” Biren said on October 8 that the BR20X had completed its initial power-on and validation, with customer sampling and mass production expected to begin over the coming quarters.
Built on Biren’s proprietary chiplet architecture, the BR20X supports low-precision FP8 and FP4 computing and can scale to as many as 1,024 GPUs in a Scale-up configuration. Biren said its performance is comparable with Nvidia’s H200.
The technical milestone, however, failed to lift the stock. Biren shares fell more than 12% at one point before closing at HK$30.36 ($3.87), down about 11.85%, giving the firm a market cap of HK$78.94 billion.
Funding overshadows the chip
The immediate trigger was not the BR20X, but a share placement announced alongside the product update.
Biren plans to sell 130 million new H shares at HK$31.08 each, a discount of about 9.76% to the previous closing price. The discounted placement will dilute existing shareholders, a factor that often weighs on Hong Kong-listed stocks.
More importantly, the deal highlights the company’s rapid funding cycle.
It is Biren’s second share placement since its January 2026 listing. In July, the company raised about HK$7 billion by selling shares at HK$46.20 each.
The 90-day lock-up period on that placement expired in early October, shortly before the latest fundraising plan was announced.
Including its IPO, Biren has now completed three equity financing rounds in less than a year, raising more than HK$10 billion in total.
The pace has prompted concerns about how much external capital the company needs to sustain its development.
Revenue is growing, but losses remain
Biren’s financial results illustrate the tension.
The company reported first-half 2026 revenue of 1.236 billion yuan ($184 million), nearly 20 times the level a year earlier, while gross margin reached 42.7%. But it still posted a net loss of 377 million yuan.
Research and development spending reached 804 million yuan, equivalent to more than 65% of revenue.
Biren said proceeds from the latest placement will be used partly to secure supply-chain capacity in advance and support mass production and delivery of the BR20X.
That strategy has a rationale. Chinese internet companies are accelerating investment in AI computing infrastructure, while domestic GPU supply remains tight.
Securing production capacity early could help Biren avoid supply constraints when demand for its new chip ramps up.
Mixed signals rattle investors
The market’s concern is that the same announcement sends two signals at once: BR20X is moving toward commercialization, but getting there requires more capital.
For Biren and other Chinese GPU makers, the problem is the timing gap between technological progress and financial returns.
A chip can be successfully powered on long before it generates meaningful revenue, while the capital required to reach mass production continues to accumulate.
The BR20X is expected to enter mass production in 2027. Its ability to turn the technical milestone into actual sales and cash flow could shape how investors view Biren’s next financing round.
Header image credit: Biren Technology official website
